Investment Management of Virginia’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $11.1M | Sell |
160,742
-1,720
| -1% | -$121K | 2.12% | 8 |
|
|
2022
Q4 | $11.7M | Sell |
162,462
-1,276
| -0.8% | -$96.2K | 2.29% | 5 |
|
|
2022
Q3 | $11.6M | Sell |
163,738
-938
| -0.6% | -$68K | 2.52% | 3 |
|
|
2022
Q2 | $12.7M | Sell |
164,676
-1,672
| -1% | -$127K | 2.61% | 3 |
|
|
2022
Q1 | $12.1M | Sell |
166,348
-934
| -0.6% | -$62.7K | 2.13% | 8 |
|
|
2021
Q4 | $10.4M | Sell |
167,282
-660
| -0.4% | -$38.7K | 1.68% | 16 |
|
|
2021
Q3 | $9.94M | Buy |
167,942
+302
| +0.2% | +$19.9K | 1.91% | 10 |
|
|
2021
Q2 | $11.2M | Sell |
167,640
-1,543
| -0.9% | -$101K | 2.16% | 7 |
|
|
2021
Q1 | $10.7M | Buy |
169,183
+315
| +0.2% | +$19.6K | 2.15% | 7 |
|
|
2020
Q4 | $10.5M | Sell |
168,868
-2,163
| -1% | -$133K | 2.28% | 7 |
|
|
2020
Q3 | $10.3M | Sell |
171,031
-4,977
| -3% | -$300K | 2.57% | 5 |
|
|
2020
Q2 | $10.3M | Sell |
176,008
-1,616
| -0.9% | -$96.7K | 2.58% | 7 |
|
|
2020
Q1 | $9.9M | Sell |
177,624
-4,761
| -3% | -$291K | 3% | 4 |
|
|
2019
Q4 | $11.7M | Buy |
182,385
+8,221
| +5% | +$471K | 2.68% | 5 |
|
|
2019
Q3 | $8.83M | Buy |
174,164
+28,003
| +19% | +$1.32M | 2.17% | 8 |
|
|
2019
Q2 | $6.63M | Buy |
146,161
+25,647
| +21% | +$1.19M | 1.59% | 17 |
|
|
2019
Q1 | $5.75M | Buy |
120,514
+73,201
| +155% | +$3.65M | 0.68% | 50 |
|
|
2018
Q4 | $2.46M | Buy |
47,313
+17,235
| +57% | +$926K | 0.64% | 50 |
|
|
2018
Q3 | $1.87M | Hold |
30,078
| – | – | 0.39% | 73 |
|
|
2018
Q2 | $1.67M | Buy |
30,078
+1,393
| +5% | +$75.2K | 0.37% | 81 |
|
|
2018
Q1 | $1.81M | Buy |
28,685
+75
| +0.3% | +$4.83K | 0.42% | 77 |
|
|
2017
Q4 | $1.75M | Sell |
28,610
-279
| -1% | -$17.5K | 0.42% | 77 |
|
|
2017
Q3 | $1.84M | Sell |
28,889
-3,701
| -11% | -$216K | 0.43% | 68 |
|
|
2017
Q2 | $1.61M | Buy |
32,590
+3,711
| +13% | +$202K | 0.39% | 72 |
|
|
2017
Q1 | $1.57M | Buy |
28,879
+250
| +0.9% | +$13.7K | 0.39% | 73 |
|
|
2016
Q4 | $1.67M | Buy |
28,629
+21,558
| +305% | +$1.18M | 0.4% | 72 |
|
|
2016
Q3 | $382K | Sell |
7,071
-600
| -8% | -$38.5K | 0.09% | 125 |
|
|
2016
Q2 | $564K | Sell |
7,671
-400
| -5% | -$28.3K | 0.14% | 123 |
|
|
2016
Q1 | $516K | Sell |
8,071
-100
| -1% | -$6.31K | 0.14% | 123 |
|
|
2015
Q4 | $562K | Hold |
8,171
| – | – | 0.15% | 125 |
|
|
2015
Q3 | $484K | Hold |
8,171
| – | – | 0.13% | 132 |
|
|
2015
Q2 | $543K | Sell |
8,171
-500
| -6% | -$33K | 0.13% | 134 |
|
|
2015
Q1 | $560K | Sell |
8,671
-85
| -1% | -$5.32K | 0.13% | 128 |
|
|
2014
Q4 | $517K | Sell |
8,756
-300
| -3% | -$16.9K | 0.11% | 129 |
|
|
2014
Q3 | $464K | Sell |
9,056
-200
| -2% | -$9.99K | 0.08% | 128 |
|
|
2014
Q2 | $449K | Hold |
9,256
| – | – | 0.07% | 132 |
|
|
2014
Q1 | $481K | Sell |
9,256
-13,425
| -59% | -$714K | 0.08% | 137 |
|
|
2013
Q4 | $1.21M | Sell |
22,681
-19,720
| -47% | -$1M | 0.2% | 115 |
|
|
2013
Q3 | $1.96M | Buy |
42,401
+15
| +0% | +$658 | 0.38% | 74 |
|
|
2013
Q2 | $1.89M | Buy |
+42,386
| New | +$1.84M | 0.42% | 68 |
|
Other funds holding BMY
Investment Management of Virginia's BMY Position: Q1 2023 in Review
Investment Management of Virginia reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2023, selling an estimated $121K and leaving 160,742 shares worth $11.1M. The position accounts for 2.12% of the portfolio, ranked #8.
Investment Management of Virginia first reported a position in BMY in Q2 2013 and has held it in 40 quarters since. The position peaked at $12.7M in Q2 2022. 2,542 funds tracked by Wall St. Rank hold BMY as of Q1 2023.
- Investment Management of Virginia held 160,742 shares of Bristol-Myers Squibb worth $11.1M as of Q1 2023.
- Investment Management of Virginia sold 1,720 Bristol-Myers Squibb shares in Q1 2023, an estimated $121K.
- Bristol-Myers Squibb made up 2.12% of Investment Management of Virginia's portfolio in Q1 2023, its #8 holding.
- Investment Management of Virginia first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 40 quarters since.
- Investment Management of Virginia's Bristol-Myers Squibb position peaked at $12.7M in Q2 2022.
- 2,542 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.
Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.